https://www.zacks.com/stock/news/2262684/molina-healthcare-moh-q1-earnings-beat-on-growing-membership?cid=CS-ZC-FT-analyst_blog|earnings_article-2262684
Apr 25, 2024 - Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.
zc:23898089247037369
0
https://www.zacks.com/stock/news/2262619/universal-health-uhs-q1-earnings-beat-on-rising-patient-days?cid=CS-ZC-FT-analyst_blog|earnings_article-2262619
Apr 25, 2024 - Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.
zc:8722146045780543479
0
https://www.zacks.com/stock/news/2263590/centene-cnc-q1-earnings-beat-on-premiums-24-eps-view-hiked?cid=CS-ZC-FT-analyst_blog|earnings_article-2263590
Apr 26, 2024 - Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
zc:-4981006403784773772
0
https://www.zacks.com/stock/news/2266339/tenet-healthcare-thc-beats-on-q1-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2266339
May 01, 2024 - Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
zc:8905285411616159177
0
https://www.zacks.com/stock/news/2268188/ensign-group-ensg-stock-down-2-4-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2268188
May 03, 2024 - Ensign Group (ENSG) expects revenues between $4.13 and $4.17 billion, the mid-point of which indicates an improvement of 11.3% from the 2023 figure.
zc:2564930917653610544
0
https://www.zacks.com/stock/news/2269026/acadia-healthcare-achc-shares-down-9-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269026
May 06, 2024 - Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.
zc:-2497324070634926759
0
https://www.zacks.com/stock/news/2269942/select-medical-s-sem-shares-up-12-9-since-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269942
May 07, 2024 - Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
zc:6972985295800910859
0
https://www.zacks.com/stock/news/2270704/pediatrix-md-q1-earnings-beat-on-hospital-contract-fees?cid=CS-ZC-FT-analyst_blog|earnings_article-2270704
May 08, 2024 - Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
zc:-8925724031656706826
0
https://www.zacks.com/stock/news/2272441/brookdale-bkd-down-3-post-q1-earnings-what-lies-ahead?cid=CS-ZC-FT-analyst_blog|earnings_article-2272441
May 10, 2024 - Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.
zc:-6237473371599897517
0
https://www.zacks.com/stock/news/2193618/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2193618
Dec 05, 2023 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:-1770176475356693203
0